BrightSpring Health Services, Inc. Common Stock · BTSG · Next earnings

BrightSpring Health Services, Inc. Common Stock next earnings report

BTSG's next report date is not on the calendar yet. Here is where the last quarter left off and what remains open. Last quarter: BrightSpring posts broad Q3 growth while IRA pressure persists

Date not yet scheduled Healthcare

What the street expects

Consensus for the coming report
Consensus EPS — Calendar consensus
Consensus revenue — Calendar consensus
Report date TBD Not yet on the calendar
Session — Session not yet known

Where BTSG left off: FY2026 Q3

Full report

BrightSpring posts broad Q3 growth while IRA pressure persists

EPS surprise — Reported — vs $0.47
Revenue surprise — Reported — vs $3.88B
Stock move +9.7% Event window
Subsequent drift 0.0% Up to 20 sessions

Management maintained its 2026 outlook and described a 2027 organic adjusted EBITDA growth target of 15% to 20%.

What to watch on the call

Carried forward from the last transcript

Risks management flagged

  • IRA-related pricing and regulatory pressure in home and community pharmacy.
  • Integration and execution risk from recent and future acquisitions.
  • Competitive pressure in specialty pharmacy, including Onco360 and CareMed.
  • Payer-mix uncertainty across specialty and infusion services.
  • Execution risk in newer services, including IG Connect, virtual primary care, and ACO participation.

Questions analysts left open

  • Whether gross profit per script and home-community pharmacy mix can remain supportive.
  • Whether specialty script growth and the LDD launch cadence are sustainable.
  • The effect of IRA-related pressure on future revenue and margins.
  • Execution and returns from acquisitions, REACH ACO, IG Connect, and virtual primary care.

Ask FN2 about BTSG next report

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Get the BTSG recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Recent BTSG quarters

All BTSG earnings

Sources

  1. FN2 corporate events calendar, resolved from the earnings calendar feed
  2. FN2 earnings calendar analyst consensus
  3. Earnings call transcript analysis, FY2026 Q3

Methodology

The report date comes from FN2's resolved corporate-events calendar and is marked estimated until the company confirms it. Consensus figures are the calendar's latest analyst estimates for the fiscal period and are not an FN2 forecast.

Risks and open questions are carried forward verbatim from FN2's structured analysis of the previous earnings call. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.